Plain-English translation of NCT06662058 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether making hearing tests more convenient — either at a location near your home or through a self-administered remote test — helps more patients with head and neck cancer stay on top of their hearing health during treatment. Cisplatin chemotherapy and radiation therapy, two common treatments for head and neck cancer, can sometimes cause hearing loss. This study wants to see if easier access to hearing checks means more patients actually get tested and catch any hearing problems early.
Hearing loss is a known side effect of the chemotherapy and radiation used to treat head and neck cancer, but many patients don't get regular hearing tests to monitor for it — especially if they live far from the hospital. This trial exists to figure out whether offering more convenient testing options, like remote or at-home hearing checks, can help more patients participate in monitoring and catch hearing problems sooner.
You likely qualify if…
You likely don't qualify if…
You will have a baseline hearing test at the hospital or clinic before or early in your treatment. Then, depending on which group you are assigned to, you will either return for in-person hearing tests at 3 and 12 months after treatment, or you may be offered the choice of a hearing test at a location closer to your home or a self-administered remote hearing test (done from home) at those same timepoints. The study will also ask you about any barriers you faced in getting your hearing tested.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States